Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_assertion type Assertion NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_head.
- NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_assertion description "[Overexpression of the receptor tyrosine kinase HER-2/neu is associated with poor prognosis in patients with breast and ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_provenance.
- NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_assertion evidence source_evidence_literature NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_provenance.
- NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_assertion SIO_000772 14612517 NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_provenance.
- NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_assertion wasDerivedFrom befree-2016 NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_provenance.
- NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_assertion wasGeneratedBy ECO_0000203 NP420219.RALDXFsqJel-N292R5cKaQR77tKyUd5uELFBciIMlX96M130_provenance.